The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?

Archive ouverte

Hergesheimer, Rudolf, C | Chami, Anna, A | de Assis, Denis Reis | Vourc’h, Patrick | Andres, Christian | Corcia, Philippe | Lanznaster, Débora | Blasco, Hélène

Edité par CCSD ; Oxford University Press -

This is the post-print version of the following article: "The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? ", which has been published in final form at https://academic.oup.com/brain/article/142/5/1176/5425269. International audience. Transactive response DNA-binding protein-43 (TDP-43) is an RNA/DNA binding protein that forms phosphorylated and ubiquitinated aggregates in the cytoplasm of motor neurons in amyotrophic lateral sclerosis, which is a hallmark of this disease. Amyotrophic lateral sclerosis is a neurodegenerative condition affecting the upper and lower motor neurons. Even though the aggregative property of TDP-43 is considered a cornerstone of amyotrophic lateral sclerosis, there has been major controversy regarding the functional link between TDP-43 aggregates and cell death. In this review, we attempt to reconcile the current literature surrounding this debate by discussing the results and limitations of the published data relating TDP-43 aggregates to cytotoxicity, as well as therapeutic perspectives of TDP-43 aggregate clearance. We point out key data suggesting that the formation of TDP-43 aggregates and the capacity to self-template and propagate among cells as a ‘prion-like’ protein, another pathological property of TDP-43 aggregates, are a significant cause of motor neuronal death. We discuss the disparities among the various studies, particularly with respect to the type of models and the different forms of TDP-43 used to evaluate cellular toxicity. We also examine how these disparities can interfere with the interpretation of the results pertaining to a direct toxic effect of TDP-43 aggregates. Furthermore, we present perspectives for improving models in order to better uncover the toxic role of aggregated TDP-43. Finally, we review the recent studies on the enhancement of the cellular clearance mechanisms of autophagy, the ubiquitin proteasome system, and endocytosis in an attempt to counteract TDP-43 aggregation-induced toxicity. Altogether, the data available so far encourage us to suggest that the cytoplasmic aggregation of TDP-43 is key for the neurodegeneration observed in motor neurons in patients with amyotrophic lateral sclerosis. The corresponding findings provide novel avenues toward early therapeutic interventions and clinical outcomes for amyotrophic lateral sclerosis management.

Suggestions

Du même auteur

Advances in disease-modifying pharmacotherapies for the treatment of amyotrophic lateral sclerosis

Archive ouverte | Hergesheimer, Rudolf | CCSD

International audience. Introduction: To date, riluzole and edaravone are the only two drugs that have successfully passed clinical trials for the treatment of Amyotrophic Lateral Sclerosis (ALS). Unfortunately, bot...

Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS

Archive ouverte | Lanznaster, Débora | CCSD

This is the accepted version of the following article: "Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS", which has been published in final form at https://www.frontiersin.org/articles/10.3389/fneur.2018...

Effect of familial clustering in the genetic screening of 235 French ALS families

Archive ouverte | Corcia, Philippe | CCSD

International audience. Objectives To determine whether the familial clustering of amyotrophic lateral sclerosis (ALS) cases and the phenotype of the disease may help identify the pathogenic genes involved. Methods ...

Chargement des enrichissements...